Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochim Biophys Acta Gen Subj ; 1863(5): 839-848, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30794825

RESUMEN

One of the main feature of chronic kidney disease is the development of renal fibrosis. Heparan Sulfate (HS) is involved in disease development by modifying the function of growth factors and cytokines and creating chemokine gradients. In this context, we aimed to understand the function of HS sulfation in renal fibrosis. Using a mouse model of renal fibrosis, we found that total HS 2-O-sulfation was increased in damaged kidneys, whilst, tubular staining of HS 3-O-sulfation was decreased. The expression of HS modifying enzymes significantly correlated with the development of fibrosis with HS3ST1 demonstrating the strongest correlation. The pro-fibrotic factors TGFß1 and TGFß2/IL1ß significantly downregulated HS3ST1 expression in both renal epithelial cells and renal fibroblasts. To determine the implication of HS3ST1 in growth factor binding and signalling, we generated an in vitro model of renal epithelial cells overexpressing HS3ST1 (HKC8-HS3ST1). Heparin Binding EGF like growth factor (HB-EGF) induced rapid, transient STAT3 phosphorylation in control HKC8 cells. In contrast, a prolonged response was demonstrated in HKC8-HS3ST1 cells. Finally, we showed that both HS 3-O-sulfation and HB-EGF tubular staining were decreased with the development of fibrosis. Taken together, these data suggest that HS 3-O-sulfation is modified in fibrosis and highlight HS3ST1 as an attractive biomarker of fibrosis progression with a potential role in HB-EGF signalling.


Asunto(s)
Riñón Fusionado/tratamiento farmacológico , Heparitina Sulfato/farmacología , Insuficiencia Renal Crónica/tratamiento farmacológico , Sulfotransferasas/antagonistas & inhibidores , Animales , Células Cultivadas , Riñón Fusionado/metabolismo , Riñón Fusionado/patología , Humanos , Ratones , Ratones Endogámicos C57BL , Insuficiencia Renal Crónica/metabolismo , Insuficiencia Renal Crónica/patología , Sulfotransferasas/genética , Sulfotransferasas/metabolismo
2.
Cancer Res ; 77(2): 268-278, 2017 01 15.
Artículo en Inglés | MEDLINE | ID: mdl-27742687

RESUMEN

Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase whose primary function is to drive collagen crosslinking and extracellular matrix stiffness. LOX in colorectal cancer synergizes with hypoxia-inducible factor-1 (HIF-1) to promote tumor progression. Here we investigated whether LOX/HIF1 endows colorectal cancer cells with full competence for aggressive colonization in bone. We show that a high LOX expression in primary tumors from patients with colorectal cancer was associated with poor clinical outcome, irrespective of HIF-1 In addition, LOX was expressed by tumor cells in the bone marrow from colorectal cancer patients with bone metastases. In vivo experimental studies show that LOX overexpression in colorectal cancer cells or systemic delivery of the conditioned medium from LOX-overexpressing colorectal cancer cells promoted tumor cell dissemination in the bone marrow and enhanced osteolytic lesion formation, irrespective of HIF-1 Conversely, silencing or pharmacologic inhibition of LOX activity blocked dissemination of colorectal cancer cells in the bone marrow and tumor-driven osteolytic lesion formation. In vitro, tumor-secreted LOX supported the attachment and survival of colorectal cancer cells to and in the bone matrix, and inhibited osteoblast differentiation. LOX overexpression in colorectal cancer cells also induced a robust production of IL6. In turn, both LOX and IL6 were acting in concert to promote RANKL-dependent osteoclast differentiation, thereby creating an imbalance between bone resorption and bone formation. Collectively, our findings show that LOX supports colorectal cancer cell dissemination in the bone marrow and they reveal a novel mechanism through which LOX-driven IL6 production by colorectal cancer cells impairs bone homeostasis. Cancer Res; 77(2); 268-78. ©2016 AACR.


Asunto(s)
Neoplasias Óseas/secundario , Neoplasias Colorrectales/enzimología , Neoplasias Colorrectales/secundario , Invasividad Neoplásica/patología , Proteína-Lisina 6-Oxidasa/metabolismo , Animales , Western Blotting , Huesos/metabolismo , Huesos/patología , Línea Celular Tumoral , Ensayo de Inmunoadsorción Enzimática , Femenino , Xenoinjertos , Humanos , Inmunohistoquímica , Interleucina-6/metabolismo , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Reacción en Cadena en Tiempo Real de la Polimerasa
3.
Bioresour Technol ; 97(4): 635-40, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15905087

RESUMEN

The aim of the present work was to assess the response of selected soil physical, chemical and biological properties, after two applications of different organic amendments to a soil with an extended horticultural use. Vermicompost from household solid waste (HSW) and from horse and rabbit manure (HRM), and chicken manure (CM) were applied at rates of 10 and 20 Mg ha(-1). The proportion of water stable soil aggregates (Ws) was significantly higher (p < 0.05) in HSW, HRM and CM at 20 Mg ha(-1). The proportion of ethanol stable soil aggregates (Es) was significantly higher in HSW, HRM and CM at 20 Mg ha(-1), and CM at 10 Mg ha(-1). After the first amendment application, HSW and HRM at 20 Mg ha(-1) resulted in higher soil organic carbon (SOC), while all the treatments showed a significant increase after the second amendment application. Linear relationships were found between Ws and Es with SOC. An increment in microbial respiration in all the amended plots was observed with the exception of HRM at the rate of 10 Mg ha(-1).


Asunto(s)
Agricultura/métodos , Estiércol/análisis , Microbiología del Suelo , Suelo/análisis , Análisis de Varianza , Carbono/análisis , Dióxido de Carbono/metabolismo , Nitrógeno
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...